OSLO: SoftOx Solutions and the Norwegian Defense Research Establishment (FFI) have signed a collaboration agreement with main focus on adapting the technology and products the company develops for military purposes both nationally and internationally.

SoftOx is developing a new class of antimicrobal agents, herunder range of wound care products for cleansing, prevention and treatment of wound infections, as well as a product for the treatment of respiratory tract infections.

Currently the company delivers alcohol-free hand and surface disinfection products with a broader effect and more unique properties than current products on the market.

The parties have a joint vision to further develop the SoftOx applications to strenghten the military and civilian preparedness against future epidemics, chemical and biological warfare, complexed wound infections and challenging conditions in the respiratory tract.

The plan is to develop a range of military SoftOx products that will be specifically targeted for the needs of the Armed Forces and for civilian purposes in conflict areas. This work will take place in close collaboration with both our national and international civilian and military partners.

“We express high expectations for this collaboration, and we appreciate that FFI has chosen to enter into a collaboration with us. Together we will be improve the safety and the preparedness of our armed forces. We also believe that this agreement will contribute to our products becoming part of the national preparedness in the fight against infections and multi-resistant bacterias, “says CEO Geir Almås in SoftOx Solutions.

Norwegian Defence Research Establishment (FFI) is the prime institution responsible for defence-related research in Norway. The Establishment is the chief adviser on defence-related science and technology to the Ministry of Defence and the Norwegian Armed Forces’ military organization. The demand for expert and flexible armed forces requires continuous renewal and Norway’s unflagging emphasize on defence technology keeps FFI busy.

It is a true challenge to make significant contributions to the development of the Armed Forces – both in its principal national defence role as well as in its various roles as an effective participant in international security operations. Relevant defence research now requires international cooperation.

In order to maintain a position at the forefront of science and technology within chosen sectors, FFI collaborates with national and international scientific institutions and industry. The Establishment also has a close working relationship with its partners and customers, (www.ffi.no)

SoftOx Solutions AS is a Norwegian BioTech company listed on Euronext Growth Oslo. Our Vison is “Helping the world fighting infections – developing new ways of eradicating infections and fighting antimicrobial resistance” We are working to combat major threats to human health, namely the emergence of antimicrobial resistance (AMR), biofilm infections in chronic wounds and the spread of viruses. www.soft-ox.com